|
|
Oestrogen-induced angiogenesis promotes adenomyosis by activating the Slug-VEGF axis in endometrial epithelial cells
|
|
|
|
|
نویسنده
|
huang t.-s. ,chen y.-j. ,chou t.-y. ,chen c.-y. ,li h.-y. ,huang b.-s. ,tsai h.-w. ,lan h.-y. ,chang c.-h. ,twu n.-f. ,yen m.-s. ,wang p.-h. ,chao k.-c. ,lee c.-c. ,yang m.-h.
|
منبع
|
journal of cellular and molecular medicine - 2014 - دوره : 18 - شماره : 7 - صفحه:1358 -1371
|
چکیده
|
Adenomyosis is an oestrogen-dependent disease characterized by the invasion of endometrial epithelial cells into the myometrium of uterus,and angiogenesis is thought to be required for the implantation of endometrial glandular tissues during the adenomyotic pathogenesis. in this study,we demonstrate that compared with eutopic endometria,adenomyotic lesions exhibited increased vascularity as detected by sonography. microscopically,the lesions also exhibited an oestrogen-associated elevation of microvascular density and vegf expression in endometrial epithelial cells. we previously reported that oestrogen-induced slug expression was critical for endometrial epithelial-mesenchymal transition and development of adenomyosis. our present studies demonstrated that estradiol (e2) elicited a slug-vegf axis in endometrial epithelial cells,and also induced pro-angiogenic activity in vascular endothelial cells. the antagonizing agents against e2 or vegf suppressed endothelial cells migration and tubal formation. animal experiments furthermore confirmed that blockage of e2 or vegf was efficient to attenuate the implantation of adenomyotic lesions. these results highlight the importance of oestrogen-induced angiogenesis in adenomyosis development and provide a potential strategy for treating adenomyosis through intercepting the e2-slug-vegf pathway. © 2014 the authors.
|
کلیدواژه
|
Adenomyosis; Angiogenesis; Epithelial-mesenchymal transition; Oestrogen; Slug
|
آدرس
|
national institute of cancer research,national health research institutes,miaoli, Taiwan, department of obstetrics and gynecology,taipei veterans general hospital,taipei,taiwan,institute of clinical medicine,national yang-ming university,taipei, Taiwan, institute of clinical medicine,national yang-ming university,taipei,taiwan,department of pathology,taipei veterans general hospital,taipei, Taiwan, department of obstetrics and gynecology,taipei veterans general hospital,taipei, Taiwan, department of obstetrics and gynecology,taipei veterans general hospital,taipei,taiwan,institute of clinical medicine,national yang-ming university,taipei, Taiwan, institute of clinical medicine,national yang-ming university,taipei,taiwan,department of obstetrics and gynecology,national yang-ming university hospital,ilan, Taiwan, department of obstetrics and gynecology,taipei veterans general hospital,taipei,taiwan,institute of clinical medicine,national yang-ming university,taipei, Taiwan, institute of clinical medicine,national yang-ming university,taipei, Taiwan, department of obstetrics and gynecology,taipei veterans general hospital,taipei, Taiwan, department of obstetrics and gynecology,taipei veterans general hospital,taipei, Taiwan, department of obstetrics and gynecology,taipei veterans general hospital,taipei, Taiwan, department of obstetrics and gynecology,taipei veterans general hospital,taipei,taiwan,institute of clinical medicine,national yang-ming university,taipei, Taiwan, department of obstetrics and gynecology,taipei veterans general hospital,taipei, Taiwan, national institute of cancer research,national health research institutes,miaoli, Taiwan, institute of clinical medicine,national yang-ming university,taipei,taiwan,division of hematology-oncology,department of medicine,taipei veterans general hospital,taipei,taiwan,immunology research center,national yang-ming university,taipei, Taiwan
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|